Summary by Moomoo AI
CONGE PHARMACEUTICAL HOLDINGS LIMITED (CMS) FILED A NEXT DAY DISCLOSURE REPORT ON APRIL 8, 2024 DISCLOSING DETAILS OF THE COMPANY'S SHARE REPURCHASE. According to the report, the company repurchased shares on April 2, 3 and 8, 2024, but did not write them off. During these three days, the Company repurchased 2,100,000 shares, 1,470,000 shares and 1,550,000 shares respectively, accounting for 0.0856%, 0.06% and 0.0633% of the issued shares. The most recent share buyback took place on 8 April 2024, when the company repurchased 1,550,000 shares on the Hong Kong Stock Exchange at a price of HKD 7.53 to HKD 7.63 for a total cost of about HKD 11,755,420. To date, the company has repurchased a total of 5,120,000 shares on the Hong Kong Stock Exchange this year to date, representing 0.2088% of the shares issued at the time. The Company confirms that all repurchases comply with the relevant rules of the HKEx and that there are no material changes.